Related Experiment Video
Updated: Oct 12, 2025
Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
Published on: August 14, 2019
Study of Selected Flavonoid Structures and Their Potential Activity as Breast Anticancer Agents
Mohammed Hadi Ali Al-Jumaili1, Muqdad Khairi Yahya Al Hdeethi2
1Department of Medical Laboratory Techniques, Dijlah University College, Baghdad, Iraq.
Abstract:
Flavonoids contain pharmacological effects that help to protect cells from damage. However, the anticancer activity of flavonoids is related to their modulation of signal transduction pathways within cancer cells. Natural substances such as flavonoids have immune-stimulating anti-tumor effect that could lower breast cancer risk. However, various diseases included Alzheimer's and cancer disease are associated with flavonoids intake due to their ability as antioxidant agent to alter essential cellular enzyme's function. Therefore, through interaction between flavonoids and Cytochrome P450 (CYP) family enzymes led to make them chemopreventive agents for breast cancer. In this analysis, the chemo-informatics properties of 5 selective flavonoid derivatives and their efficiency as anti-breast cancer drugs were evaluated. Flavonoid ligands were docked with the predicted protein, which is human placental aromatase complexes with exemestane, a breast cancer drug (3S7S). Based on various docking energies, the molecular characteristics and bioactivity score of the following components, C15H12O6 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-4H-chromen-4-one and C15H12O5 5,8-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one showed greatest molecular properties and bioactivity docking scores of -8.633117 and -8.633117 kcal/mol respectively. Therefore, both compounds could be considered antitumor agent.
Insights
Flavonoids show potential as breast cancer treatments by interacting with Cytochrome P450 enzymes. Two specific flavonoid derivatives demonstrated significant molecular properties and bioactivity, suggesting their use as antitumor agents.
Area of Science:
- Pharmacology
- Biochemistry
- Computational Chemistry
Background:
- Flavonoids possess pharmacological effects, including cell protection and immune stimulation, with potential anti-tumor properties relevant to lowering breast cancer risk.
- Flavonoid intake is linked to various diseases, including cancer, due to their antioxidant capabilities and alteration of cellular enzyme functions.
- The interaction between flavonoids and Cytochrome P450 (CYP) enzymes positions them as potential chemopreventive agents for breast cancer.
Purpose of the Study:
- To evaluate the chemo-informatics properties and anti-breast cancer drug efficiency of five selective flavonoid derivatives.
- To assess the molecular characteristics and bioactivity of flavonoid ligands through docking simulations.
Main Methods:
- Chemo-informatics analysis of five selective flavonoid derivatives.
- Molecular docking of flavonoid ligands with the human placental aromatase protein complexed with exemestane (3S7S).
Main Results:
- Two flavonoid derivatives, C15H12O6 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-4H-chromen-4-one and C15H12O5 5,8-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one, exhibited the highest molecular properties and bioactivity docking scores (-8.633117 kcal/mol).
Conclusions:
- The evaluated flavonoid derivatives show promising molecular characteristics and bioactivity.
- These compounds could be considered potential antitumor agents for breast cancer treatment.
More Related Videos
Related Concept Videos
02:59Cancer Prevention
Some...
01:28Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...